4.2
Enfermedad Pulmonar Obstructiva Crónica II: Fisiopatología
La fisiopatología de la enfermedad pulmonar obstructiva crónica (EPOC) es compleja y multifacética, e implica una interacción compleja de procesos fis…
La enfermedad pulmonar obstructiva crónica, o EPOC, es causada principalmente por la inflamación crónica de las vías respiratorias debido a la exposición a irritantes como el humo del cigarrillo, el polvo o la contaminación del aire.
Las células inflamatorias, incluidos los linfocitos, los macrófagos y los neutrófilos, invaden la pared de las vías respiratorias y liberan mediadores dañinos como leucotrienos y citocinas.
Las partículas inhaladas y los oxidantes producidos por estas células inflamatorias agravan la inflamación.
Los oxidantes inhiben los compuestos antiproteasas que protegen contra la descomposición del tejido pulmonar.
Al mismo tiempo, aumentan la actividad de las enzimas proteasas que degradan el tejido pulmonar.
Este desequilibrio altera el equilibrio natural entre proteasas y antiproteasas, lo que provoca el deterioro de los alvéolos y la pérdida de elasticidad pulmonar.
Como resultado, las vías respiratorias se estrechan, obstruyendo el flujo de aire, lo que promueve la producción excesiva de moco y provoca la acumulación de líquido en los pulmones.
En la EPOC, la inflamación crónica causa estrés oxidativo, liberando radicales libres que dañan el tejido pulmonar, lo que conduce a la formación de ampollas y al deterioro de la pared alveolar, lo que perjudica el intercambio de gases.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic airway inflammation in COPD?
COPD develops from chronic exposure to irritants like cigarette smoke, dust, and air pollution. These irritants trigger inflammatory cells—lymphocytes, macrophages, and neutrophils—to infiltrate airway walls and release harmful mediators such as leukotrienes and cytokines. This perpetuates ongoing inflammation and progressive lung damage characteristic of the disease.
Q2: How does the protease-antiprotease imbalance damage lung tissue in COPD?
Oxidants from cigarette smoke impair antiproteases like alpha-1 antitrypsin that normally protect lung tissue. Simultaneously, oxidants increase protease activity, particularly elastase, which degrades extracellular matrix components. This imbalance causes destruction of alveolar walls and lung parenchyma, leading to emphysema and loss of lung elasticity.
Q3: What role do free radicals play in COPD pathophysiology?
Chronic inflammation generates reactive oxygen species (ROS) like superoxide anions and hydroxyl radicals from cigarette smoke and inflammatory cells. These free radicals damage cellular structures, proteins, lipids, and DNA, further promoting inflammation and lung tissue deterioration. This oxidative stress perpetuates the cycle of tissue destruction in COPD.
Q4: How does airway narrowing occur in COPD?
Chronic inflammation causes structural changes and constriction in airways, reducing airflow. Mucus hypersecretion and mucosal edema exacerbate narrowing, while smooth muscle constriction further impedes airflow. Additionally, increased vascular permeability from inflammation leads to fluid accumulation in lungs, contributing to obstruction and airway blockage.
Q5: What structural changes occur in the lungs during COPD?
Ongoing tissue destruction causes alveolar enlargement and bullae formation—large air pockets within lung tissue. Destruction of alveolar walls reduces surface area for gas exchange, impairing oxygen uptake and carbon dioxide elimination. These structural changes decrease lung compliance and elasticity, leading to reduced oxygen uptake and shortness of breath.
Q6: How do inflammatory mediators perpetuate lung damage in COPD?
Inflammatory cells release cytokines, leukotrienes, and other mediators that perpetuate the inflammatory response. These mediators recruit additional inflammatory cells and sustain the release of proteases and oxidants. This creates a self-perpetuating cycle of inflammation and tissue destruction that characterizes COPD progression.
Q7: Why is gas exchange impaired in COPD?
Destruction of alveolar walls reduces the surface area available for oxygen and carbon dioxide exchange. Combined with fluid accumulation and airway obstruction, these structural changes impair gas exchange efficiency. Understanding these mechanisms is essential for developing effective chronic obstructive pulmonary disease management strategies.